로딩 중…
지수 로딩 중…
Dyne Therapeutics, Inc.
DYN· NASDAQ· Health Care· Pharmaceuticals, Biotechnology & Life Sciences
$19.80+3.13%
2026-06-18
Price Chart
Dyne Therapeutics, Inc.+83.67%
Financials
No data
※ FY = Fiscal Year
Investment Metrics(as of 2026-06-18)
| Metric | Value |
|---|---|
| Size | |
| Market Cap | $3.27B |
| Revenue | $0.00 |
| Net Income | $-452M |
| Total Assets | $1.08B |
| Net Assets | $865M |
| Value | |
| P/B | 3.78x |
| FCF Yield | -14.12% |
| Profitability | |
| ROE | -52.22% |
| ROA | -41.83% |
| Financial Health | |
| Debt Ratio | 24.84% |
| Total Debt | $19M |
| FCF | $-462M |
| Cash | $753M |
| Current Ratio | 19.92x |
| Performance | |
| 1Y Return | 83.67% |
| 1M Return | 24.37% |
| From 52W High | -20.80% |
| 1Y MDD | -44.65% |
| Trading | |
| Volume | 4,274,486 shares |
| Trading Value | $85M |
| Per Share | |
| EPS | $-3.47 |
| BPS | $7.57 |